Apparatus for multi-step synthesis of organic molecules

Abstract

To provide an improved device for producing oligonucleotides and polypeptides which overcomes batch process limitations.SOLUTION: A device for multi-stage synthesis of organic molecules comprises the following in combination:: (a) a plurality of reaction vessels; (b) a plurality of fluid reservoirs; (c) valve elements associated with the fluid reservoirs; (d) a fluid supply device for providing a feed stream from the fluid reservoir to the vessels; (e) a plurality of devices capable of monitoring a chemical composition of effluent from the plurality of the vessels; and (f) a conveyor having a programmed pattern suitable for sequentially conveying the vessels from a fluid engagement with one fluid reservoir to the next fluid reservoir according to the programmed pattern.SELECTED DRAWING: Figure 1

Description

Technical Field

[0001] This application claims the benefit of U.S. Provisional Application No. 62 / 831,853, filed Apr. 10, 2019, the disclosure of which is incorporated herein by reference.

Background Art

[0002] The present embodiment relates to a system and method for synthesizing molecules. More specifically, the present embodiment relates to an apparatus and method for synthesizing biological polymers such as polypeptides and oligonucleotides. However, it should be understood that the present embodiment is also applicable to other similar applications.

[0003] An oligonucleotide is a polymer consisting of a sequence of nucleosides containing a sugar and a nucleobase. Each nucleoside is spaced from an adjacent nucleoside by an internucleosidic linkage, which effectively serves as a bond between the nucleosides. The sugar may be a pentose such as deoxyribose, ribose, or 2'-O-substituted ribose. Many different bases and substituted bases can be used, the most common four being adenine, cytosine, guanine, and thymine (abbreviated A, C, G, T, respectively). The internucleosidic linkage is most commonly phosphoric acid and may be substituted with various substituents at the non-bridging oxygen atoms, most commonly with sulfur or an alkyl, ester, or amide group.

[0004] Oligonucleotides are among the most important and common reagents used in biotechnology laboratories engaged in research, diagnosis, and therapy. The high demand for oligonucleotides stems from their specificity for complementary nucleotide sequences in DNA or RNA obtained from biological samples. Different methods are used to synthesize oligonucleotides, including the phosphoramidite method, the phosphotriester method, and the H-phosphonate method, each of which is commonly known in the field of biochemistry.

[0005] Solid-phase-based multi-step synthesis of complex organic molecules using controlled fluids via a fixed bed is a popular methodology for nucleic acid synthesis. This common technique is widely applied to the synthesis of peptides, oligonucleotides, and similar long-chain biological polymers. A comprehensive discussion of the chemical and synthetic techniques for oligonucleotide production is provided in E. Paredes, V. Aduha, KL. Ackley, and H. Cramer, “Manufacturing of Oligonucleotides,” Comprehensive Medical Chemistry, 3rd Edition, 2017, Elsevier Inc., which is incorporated herein by reference.

[0006] The commercial production of a wide variety of oligonucleotides is becoming increasingly important as these substances move out of the laboratory and into mainstream therapeutic applications. Commercially available oligonucleotides are typically at least 6 nucleotides long, sometimes 12 to 50 nucleotides, with 15 to 30 nucleotides being the most common length.

[0007] In one system for producing oligonucleotide molecules, a solid support can be provided in the reaction vessel, and a number of dimethoxytrityl (DMT) protected nucleosides can be immobilized on the solid support. A deprotecting agent acting via a detritylation mechanism is added to remove DMT from the nucleosides and "deprotect" the hydroxyl groups. As a result, the terminal nucleosides of the sequence have one hydroxyl group ready to receive the next amidite. Nucleoside phosphoramidete (hereinafter referred to as "amidite") dissolved in a solvent such as acetonitrile (ACN) is introduced into the vessel. An activator may be introduced into the vessel along with the amidite. The phosphorus in the amidite combines with the oxygen in the hydroxyl groups, thereby providing nucleotides bound to the support. After the nucleotides bound to the support are formed, excess amidite may be washed out of the vessel with ACN. An oxidizing agent may then be added to convert trivalent phosphorus to pentavalent phosphorus. After the oxidizing agent has been flushed, a capping agent can be added to block the unprotected hydroxyls from reacting with the amidite introduced in a later step. ACN may be reintroduced to wash away the capping agent. These steps can be repeated multiple times to create oligonucleotide chains extending from nucleosides bound to a support.

[0008] Conventional synthesis apparatuses employ a flow-through design where various lines, pumps, and valves are constantly filled with liquid, and the liquid is introduced into containers called columns. Columns are typically flow-through devices where newly introduced liquid replaces previously introduced liquid. In many large-scale manufacturing facilities, high throughput is achieved by using arrays of synthesis apparatuses in batch processes. These synthesis apparatuses are typically configured to perform individual steps of a monomer addition cycle sequentially, allowing for parallel processing of several different oligonucleotides. Thus, a series of reactions for multiple oligonucleotides proceeds in such a way that each oligonucleotide undergoes detritylation, followed by coupling, then capping, and finally oxidation. This cycle is then repeated until the full-length oligonucleotide is obtained.

[0009] To produce biomacromolecules (e.g., oligonucleotides, peptides, etc.) on a large scale, widely accepted solid-phase synthesis approaches can be used. In this method, a starting monomer is bonded to an insoluble matrix via an unstable linker. The necessary reactants and additional reactive monomers are added to this matrix to extend the oligomeric compound onto insoluble beads. Specifically, a solid-phase synthesis cycle for the production of oligonucleotides can generally be carried out in four iterative steps. First, a solid support bearing the first nucleoside or auxiliary residue is placed on a solid support housing. The support is then treated with a deprotecting agent solution to remove masking groups, generally DMT protecting groups on hydroxyl groups. The newly unmasked hydroxyl group is free to react with the next desired residue in the oligomeric sequence in subsequent steps. In this case, the next residue is added as a phosphoramidite monomer mixed with an activator used to promote the reaction. The newly formed phosphotryster is not sufficiently stable for the remainder of the synthesis and is therefore generally stabilized by oxidation, thiolation, or other methods. Before restarting the next cycle, unreacted species are inactivated by the use of a capping reagent. This remasks the unreacted hydroxyl groups, preventing further elongation in subsequent coupling cycles. By repeating the four steps (demasking, coupling, linkage stabilization, and capping), oligonucleotides of various lengths can be generated. The complex process of solid-phase oligomer synthesis can be simplified by using a solid-phase synthesizer.

[0010] Large-scale nucleic acid synthesis using a single large column requires either a long support layer in the flow direction (hereinafter referred to as "column length") or a wide diameter. However, both column diameter and column length are limited due to flow distribution and high operating back pressure. Under these circumstances, uniform mass transfer is difficult. Therefore, there are inherent limitations on the feasible column size, and thus the manufacturing size. Consequently, the length of typical commercially available oligonucleotides is limited to 15-40 Mer. [Overview of the project] [Problems that the invention aims to solve]

[0011] The demand for oligonucleotides is constantly expanding, and therefore, there is a desire for the ability to produce as many oligonucleotides as possible inexpensively, quickly, with high quality and high yield. This disclosure describes improved continuous processes and improved apparatus for the production of oligonucleotides and polypeptides that overcome the limitations of batch processes. [Means for solving the problem]

[0012] To provide a basic understanding, various details of this disclosure are summarized below. This summary is not intended to be a broad overview of the disclosure, nor is it intended to identify or describe the scope of any specific element of the disclosure. Rather, the main purpose of this summary is to present some of the concepts of the disclosure in a simplified form prior to the more detailed explanation presented below.

[0013] According to the first embodiment, a nucleic acid synthesis method is provided. The method uses an apparatus comprising at least one deprotection unit that performs a deprotection step, at least one coupling unit that performs a coupling step, at least one oxidation / thiolation unit that performs an oxidation or thiolation step, and at least one washing unit that performs a washing step. Multiple reaction vessels or "pots" for nucleic acid synthesis are moved to the above units according to a synthesis scheme for a desired nucleic acid sequence, and at least two reaction vessels are arranged in a row and act simultaneously in several units.

[0014] According to another embodiment, a nucleic acid synthesis method is provided. This method uses an apparatus for the multi-step synthesis of organic molecules with increasing chain length. The apparatus comprises at least one deprotection station for carrying out a deprotection step; at least one coupling station for carrying out a coupling step; at least one oxidation / thiolation station for carrying out an oxidation or thiolation step; at least one capping station for carrying out a capping step; and at least one washing station for carrying out a washing step. Each station includes a suitable fluid reservoir. According to a synthesis scheme for constructing a selected nucleic acid sequence, a plurality of nucleic acid synthesis vessels are moved in parallel to the stations via a conveyor device, with at least one station carrying out a reaction requiring the longest time (R) compared to the other stations. At least the majority of the vessels are moved simultaneously (but not necessarily to all stations at the same time) between the stations according to a set time (T), and the vessels remain at stations having a reaction time of a multiple of T and less than R.

[0015] According to the device embodiments of the present disclosure, an apparatus for the multi-step synthesis of organic compounds is provided. The apparatus comprises a combination of (a) a plurality of reaction vessels; (b) a plurality of fluid reservoirs; (c) valve elements associated with the fluid reservoirs; (d) a fluid supply device for providing a supply stream from the fluid reservoirs to the vessels; (e) a plurality of devices capable of monitoring the chemical composition of effluents from the plurality of vessels; and (f) a conveyor having the programmed pattern suitable for sequentially transporting the vessels from fluid engagement with one fluid reservoir to the next fluid reservoir according to the programmed pattern.

[0016] In yet another embodiment, an apparatus for the multi-step synthesis of organic compounds is provided. The apparatus comprises: (a) a conveyor containing a plurality of reaction vessels, the conveyor being movable on or around an axis; (b) a device for moving the conveyor in steps, each of which docks each of the vessels to one of a plurality of fluid reservoirs in each incremental step; (c) a fluid supply device for supplying liquid from the fluid reservoirs to each of the vessels at each docking station; (d) a drainage system for discharging liquid outflow from each of the vessels at each docking station to one of a plurality of designated vessels; and (e) a programmable computer for controlling the conveyor, the fluid supply device, and the drainage system.

[0017] In an additional embodiment, a reaction apparatus is disclosed for sequentially carrying out a process for constructing biomolecules. The apparatus comprises a plurality of separate reaction vessels, each containing a support on which the molecules can be bound. A plurality of fluid reservoirs capable of containing fluids for carrying out the steps of the process are also provided. A conveyor individually places each vessel into a fluid contact mode with each of the fluid reservoirs. The conveyor positions the vessels in a continuous fluid contact mode with at least a first fluid reservoir and a second fluid reservoir. The vessels can sequentially come into contact with the contents of each of the fluid reservoirs, which are the contents for sequentially processing the molecules. At least one operating mode of the apparatus allows at least two of the vessels to simultaneously receive fluid from a single fluid reservoir.

[0018] According to another embodiment, a nucleic acid synthesis apparatus is provided. This apparatus comprises at least one detritylation station for carrying out a detritylation step; at least one coupling station for carrying out a coupling step; at least one oxidation / thiolation station for carrying out an oxidation or thiolation step; at least one capping station for carrying out a capping step; and at least one washing station for carrying out a washing step. Each station includes a suitable fluid reservoir, and the stations are operated in parallel. The apparatus allows for the movement of multiple nucleic acid synthesis vessels to the stations via a conveyor device according to a synthesis scheme for constructing a selected nucleic acid sequence of at least 100 Mer.

[0019] According to another embodiment, a peptide manufacturing process is provided. This process uses a device for multi-step synthesis that activates consecutive amino acids to a carboxyl group-activated state and continuously links them to an activated site through the carboxyl terminus. The device includes at least one detritylation station; at least some stations for supplying aliquots of appropriate amino acids; at least one station for performing a washing step; at least one station for performing a neutralization step; and at least one station for performing a coupling step. Each station includes an appropriate fluid reservoir. This process simultaneously moves a plurality of peptide synthesis vessels to the stations via a conveyor device according to a synthesis scheme for constructing a selected amino acid sequence. This process arranges at least two peptide synthesis vessels in a row and positions them to act simultaneously at several of the stations.

Brief Description of Drawings

[0020] The following is a brief description of the drawings presented for the purpose of illustrating exemplary embodiments disclosed herein and is not presented for the purpose of limiting the drawings. [Figure 1] FIG. 1 is a schematic diagram of a system according to the present disclosure. [Figure 2A] FIG. 2A provides a schematic view of a continuous side of the present disclosure. [Figure 2B] FIG. 2B provides a schematic view of a continuous side of the present disclosure. [Figure 2C] FIG. 2C provides a schematic view of a continuous side of the present disclosure. [Figure 2D] FIG. 2D provides a schematic view of a continuous side of the present disclosure. [Figure 2E] FIG. 2E provides a schematic view of a continuous side of the present disclosure. [Figure 2F] FIG. 2F provides a schematic view of a continuous side of the present disclosure. [Figure 2G] FIG. 2G provides a schematic view of a continuous side of the present disclosure. [Figure 2H] Figure 2H provides a schematic view of a continuous side surface of the present disclosure. [Figure 2I] Figure 2I provides a schematic view of a continuous side surface of the present disclosure. [Figure 2J] Figure 2J provides a schematic view of a continuous side surface of the present disclosure. [Figure 2K] Figure 2K provides a schematic view of a continuous side surface of the present disclosure. [Figure 2L] Figure 2L provides a schematic view of a continuous side surface of the present disclosure. [Figure 2M] Figure 2M provides a schematic view of a continuous side surface of the present disclosure. [Figure 2N] Figure 2N provides a schematic view of a continuous side surface of the present disclosure. [Figure 2O] Figure 2O provides a schematic view of a continuous side surface of the present disclosure. [Figure 3] Figure 3 provides a schematic view of a suitable simplified second continuous step following the process of Figure 2. [Figure 4] Figure 4 provides a schematic view of a suitable simplified third continuous step following the process of Figure 3. [Figure 5] Figure 5 provides a schematic view of a suitable simplified fourth continuous step following the process of Figure 4. [Figure 6] Figure 6 provides a schematic view of a suitable simplified fifth continuous step following the process of Figure 5. [Figure 7] Figure 7 provides a schematic view of each of the first to fifth continuous steps implemented in parallel. [Figure 8] Figure 8 is a schematic view showing the integration of multiple stages. [Figure 9] Figure 9 is a schematic view of a reaction vessel or pot. [Figure 10] Figure 10 is a schematic view showing how to cope with the variation of reaction time when using a serial protocol. [Figure 11]Figure 11 is a schematic diagram illustrating how to address reaction time variability using a parallel protocol. [Modes for carrying out the invention]

[0021] A more complete understanding of the components, processes, and apparatus disclosed herein can be obtained by referring to the accompanying drawings. These drawings are merely schematic representations based on convenience and ease of explanation for this disclosure and are not intended to show the relative sizes and dimensions of the apparatus or its components and / or to define or limit the scope of the exemplary embodiments.

[0022] In the following description, certain terms are used for clarity, but these terms are embodiments selected for illustrative purposes in the drawings and are not intended to define or limit the scope of the disclosure. In the following drawings and description, similar reference numerals should be understood to refer to components of similar function.

[0023] The singular forms "a," "an," and "the" refer to multiple objects unless explicitly indicated by the context.

[0024] As used herein, the terms “about,” “generally,” and “substantially” are intended to include structural or numerical modifications that do not significantly affect the purpose of the element or number modified by such terms.

[0025] Where used herein, specific synthetic steps are described broadly, sometimes as specific chemical reactions. For example, the term deprotection is used to describe the step of removing a masking group, and detritylation is used to describe the specific removal of a DMT (4,4'-dimethoxy) group by an acidic solution. However, these terms can be used interchangeably to describe steps in oligonucleotide synthesis.

[0026] Where used herein, a numerical range specified by an endpoint includes all numbers contained within that range (for example, 1–5 includes 1, 1.5, 2, 2.75, 3, 3.6, 4, 5, etc.). Similarly, when multiple ranges are specified for an item, the ranges are intended to reflect various combinations thereof (for example, 1–5 or 2–3 also includes the ranges 1–3 and 2–5).

[0027] As used in the specification and claims, the term “comprising” may include embodiments of “consisting of” and “consisting essentially of.” The terms “comprise(s),” “include(s),” “having,” “has,” “can,” “contain(s),” and their variations as used herein are intended to be open-ended transitional phrases, terms, or words that require the presence of a specified component / step and allow the presence of other components / steps. However, such descriptions shall be interpreted as also describing a composition or method as “consisting of” and “essentially consisting of” the enumerated components / steps, which allows the presence of only the specified component / step and excludes other components / steps, along with any impurities that may arise therefrom.

[0028] Figure 1 shows the basic components of the synthesis apparatus 2 of this disclosure. The configuration includes reactant / reagent supply containers 4 containing liquids for carrying out necessary synthesis steps such as washing (e.g., ACN), detritylation (e.g., dichloroacetic acid (DCA) / toluene), coupling (e.g., ACN, amidite, activator), thiolation (e.g., pyridine / ACN), capping (e.g., pyridine / ACN / N-methylimidazole (NMI)), and post-synthesis washing (e.g., TBA / ACN). The term reactant is used to identify the liquid used to extend the oligomer. The term reagent is used to identify the liquid used for preparing and / or activating the synthesis process. Multiple unlabeled supply containers are shown to demonstrate that the synthesis apparatus can accommodate any appropriate additional supply materials required by the intended synthesis. Similarly, the materials exemplified are not necessarily required for all synthesis processes.

[0029] The synthesis apparatus 2 further includes a supply container 4 and a pump 6 (or fluid injector) capable of circulating fluid. The pump 6 supplies selected reagents / reactants to a valve 8 for supply to the reaction pot 10. The valve may be a block valve. A flow meter 12 may be provided to monitor the amount of reagents / reactants being introduced. The flow meter and valve can work in cooperation with a control device such as a PLC 14 to provide fluid supply control to deliver precise amounts to each reaction pot at the reaction station, which will be described in more detail below.

[0030] At least one analytical instrument 16, such as a UV spectrometer, may be attached to the apparatus to monitor steps in the molecular synthesis process. The operation and monitoring of the pump 6, flow meter 12, block valve 8, and analytical instrument 16 can be controlled by a programmable logic controller (PLC) 14. As those skilled in the art will recognize, piping 18 is provided throughout the synthesis apparatus, but in the drawings, for the sake of improved visibility, it is shown only where its presence better conveys the conceptual features of the present invention. For example, piping can be provided to transport reaction residue from the reaction pot 10 to a collection container 20. This improves the recycling of reagents / reactants and also allows the collected material to be reused in the process. The synthesis apparatus 2 includes a number of individual reaction pots 10, these reaction pots associated with a conveyor mechanism 22, such as a moving belt. The tops of 11 reaction pots are arranged on the conveyor mechanism. The conveyor mechanism may be circular, linear, or zigzag in shape.

[0031] The components of the synthesis apparatus, particularly those in direct contact with reagents / reactants, can be formed from suitable materials such as stainless steel, polyetheretherketone, and / or polytetrafluoroethylene. It is recommended that the synthesis apparatus be manufactured in accordance with FDA regulations, e.g., cGMP in CFR 21 Part 117. Furthermore, it is conceivable that the synthesis apparatus be housed and / or operated in a controlled environment that can be purged with an inert gas such as argon or a less reactive gas such as nitrogen.

[0032] Each reaction station (see, for example, Figure 1) may be equipped with at least one supply container, at least one pump, at least one flow meter, and at least one control valve. Of course, appropriate piping is provided to supply the appropriate reagents / reactants to a particular station. Depending on the reaction requirements and the type of reagents, each station is expected to have the capacity to disperse the relevant reagents / reactants at a volume of approximately 10 to 1000 ml / min.

[0033] Each supply container, in combination with the associated pumps, piping, flow meters, valves, analyzers, and collection containers, can be considered a reaction station or a processing station. Any of the equipment associated with the station may be heated or cooled, and / or may include a source of pressurized gas for processing the pumps, valves, piping, and / or containers. Each station may further comprise one or more separation units, filtration units, membrane extraction units, and / or chromatography units.

[0034] In this case, the PLC 14 communicates with the synthesis device via wired or wireless feedback lines, and the PLC maintains the position of the reaction pods in real time. Position sensors can be provided to monitor the position of the reaction pods. The PLC controls the movement of the reaction pods 10 through a reaction protocol and connects individual pods and stations according to a programmed synthesis process, allowing fluid to flow between them.

[0035] Synthesis can also be controlled via a PLC. Instructions from the PLC control the timing, volume, flow rate, and sequence of introducing reagents / reactants into the reaction pot, thereby determining the sequence of oligomer synthesis. These instructions, such as instructions to open and close various valves, instructions to move conveyors / reaction pots, instructions to operate various pumps, and instructions to monitor flow meters or analyzers, can be linked to master commands related to the construction of long-chain molecules of a specific structure.

[0036] The PLC may be programmable so that the device can be reprogrammed to prepare a "batch" of multiple reaction pots of a first long-chain molecule, and then to prepare a batch of multiple reaction pots of different long-chain molecules.

[0037] Multiple (or all) stations may be equipped with analytical instruments such as UV spectrometers to analyze either or both the reaction products in the reaction pot 10 or the residues collected from the reaction pot 10. In addition, or as an alternative to UV spectrometers, the system may also be equipped with a liquid chromatography-mass spectrometer (LCMS), a light monitor, a temperature monitor, an infrared monitor, an NMR spectrometer, and / or a Raman spectrometer for quality control. Preferably, the system allows reaction pots exhibiting unsatisfactory results, such as synthesis errors or molecules with incomplete reactions, to be removed from the conveyor mechanism or otherwise excluded from further processing steps. This allows the effects of a failed reaction step to be contained to a single reaction pot, preventing contamination of the entire production process.

[0038] Figures 2A-2O show the continuous nature of the synthesis process related to this apparatus. Specifically, in Figure 2A, the first reaction pot 1 is introduced to the first station (pre-synthesis cleaning). Reaction pot 2 is then positioned to be picked up by the conveyor mechanism.

[0039] The illustrated sequence of steps is, of course, illustrative. Furthermore, each step does not necessarily have to be performed in the exact order shown. For example, amino rinsing at the end of each step is not required. Similarly, the illustrated steps do not have to be performed using the listed chemicals. Rather, alternative fluids capable of performing similar / identical functions are known in the art.

[0040] Reaction pot 1 (and subsequent pots) may include a support such as NittoPhase® HL. A frit or filter cloth can be placed inside the reaction pot to host the support. Given the relatively small size of the reaction pot, the pressure drop is relatively small, and therefore the support may contain particles smaller than conventional particles (e.g., less than 80 μm, or less than 40 μm, or less than 1 μm, or less than 0.3 μm). Note that liquid-phase synthesis is also possible.

[0041] Reaction pot 1 first receives ACN, associated with a station for pre-synthesis cleaning. A waste liquid collection container is connected to the reaction pot at the pre-synthesis station to recover excess ACN for recycling. Each station may have its own pump for introducing liquid from the supply container. Each station may also include its own flow meter to control the rate of fluid introduction to match the kinetics of the reaction / process occurring at that station. Furthermore, each station may include its own control valve (or a series of control valves) to ensure that a sufficient amount of fluid is supplied to the reaction pot to complete the associated reaction / process. In addition, multiple control valves may be provided at a station, thereby allowing multiple reaction pots to be processed simultaneously.

[0042] In Figure 2B, while reaction pot 2 enters the conveyor mechanism and is placed at the first station for pre-synthesis cleaning, reaction pot 1 moves to the second station for detritylation. Reaction pots 1 and 2 can each be placed at their respective synthesis stations for at least approximately the same amount of time. The second station may operate at a different flow rate and / or volume than the first (or subsequent) station. This is also true for other stations in the apparatus.

[0043] The second station may include a UV spectrometer 16 or other analytical device, which can be used to evaluate the state of reaction pot 1 and / or its residue. The second station is provided with a separate waste liquid collection (recycling) container for collecting and recycling excess reagents. This is also the case for the other stations of the apparatus.

[0044] In Figure 2C, the conveyor mechanism moves reaction pot 1 to a third station for a second detritylation stage, to which different concentrations of DCA / toluene are supplied. At least substantially simultaneously, reaction pot 2 is moved to a second station by the conveyor mechanism for a first detritylation treatment, and reaction pot 3 enters the first station of the apparatus for pre-synthesis cleaning. A UV spectrometer is provided to evaluate the content of reaction pot 1 and / or its residues in the third station.

[0045] Since the same pumps, piping, and valve systems are used with the same reagents at each station, there is no need to drain or clean liquid residues between synthesis steps. This advantage extends to the transition from the synthetic sequence forming the first molecule to the synthetic sequence configured to form the second molecule. This improves processing speed and reduces waste liquid.

[0046] In Figure 2D, reaction pot 1 reaches the fourth station for coupling, while reaction pot 4 is picked up by a conveyor mechanism and transported to the first station for pre-synthesis cleaning. Each of the reaction pots 1-4 operates at least substantially simultaneously at their respective stations. The coupling station is shown with three reaction pots that may have been prior to reaction pot 1 (only three reaction pots are shown for illustrative purposes). By using counter-current flow, exceptional efficiency is provided in relation to the introduction of relatively expensive phosphoramidite. Furthermore, the amount of phosphoramidite waste can be reduced compared to conventional batch processing.

[0047] The reaction pots in the coupling station can move simultaneously with other reaction pots in the array, but remain fluid-flowable between the coupling station and the reaction pots during multiple active periods (i.e., the time the reaction pots receive fluid from the station). Bidirectional liquid flow allows for simultaneous processing of multiple reaction pots. In Figure 2D, four reaction pots simultaneously receive amidite reaction feed thymine, ACN, and an activator (such as ethylthio-1H-tetrazole (ETT)). The amidite feed can be at a concentration greater than that required for one reaction pot. Amidite can be introduced into the first reaction pot in an amount greater than the stoichiometric requirement of 3:1. For example, phosphoramidite can be added in an amount of approximately 0-5.0 equivalents or approximately 1.5-3.0 equivalents of the reaction capacity based on the volume of the support. Excess amidite moves to the reaction pots connected in a row. In this way, unreacted amidite from one sequentially linked reaction pot flows to the next reaction pot, is picked up for molecular construction, and phosphoramidite loss can be significantly reduced compared to batch processing.

[0048] In certain synthesis processes, it may be desirable to provide intermittent and / or pulsed washing during the coupling process. Furthermore, pulsed washing can be used to remove unreacted amidite that might not otherwise flow readily into the downstream reaction pot. Washing can be performed with a liquid such as ACN, a gas such as N2, or a combination thereof.

[0049] The introduced amidite is added to the extension molecule. By sequentially linking reaction pots and then moving the chain of bidirectional flow upwards, this process ensures proper molecular construction by exposing the reaction pots to the stoichiometrically highest concentration of amidite at the final position of the coupling station. In short, the "residual" amidite from one reaction pot is used to "pre-treat" subsequent reaction pots, reducing wastewater. It should also be noted that the bidirectional flow method used in connection with the amidite supply station is equally suitable for use in any or all of the other stations of the synthesis apparatus.

[0050] Figures 2E to 2G show that as the reaction pots are moved downstream on the conveyor mechanism, reaction pots 5, 6, and 7 newly join the continuous movement of the reaction pots, and reaction pots 2, 3, and 4 join reaction pot 1 of the thymine coupling station in a bidirectional flow configuration.

[0051] Figures 2H and 2I show how reaction pot 1 and reaction pot 2 move sequentially to the coupling cleaning station, respectively. The coupling cleaning station can also be configured for bidirectional flow. An example is shown where two reaction pots are lined up in a row and receiving the coupling fluid. Of course, more than two reaction pots can be connected in a row. As is clear, new reaction pots (reaction pots 8 and 9) follow these reaction pots in sequence.

[0052] In Figures 2J and 2K, reaction pot 1 and reaction pot 2 are sequentially moved to the thiolation station (pyridine / ACN). Clearly, these reaction pots are followed in sequence by new reaction pots (reaction pots 10 and 11).

[0053] Figures 2L and 2M show that reaction pot 1 and reaction pot 2 are sequentially moved to the capping station (pyridine / ACN / NMI / AC20) using a bidirectional flow configuration, respectively. As is clear, new reaction pots (reaction pots 13 and 14) follow these reaction pots in sequence.

[0054] Figures 2N and 20 show that reaction pot 1 and reaction pot 2 are sequentially moved to the post-synthesis amine washing station, respectively. In the synthesis process, these reaction pots are followed in sequence by new reaction pots (reaction pots 15 and 16). After the completion of post-synthesis amine washing, the exemplary first synthesis stage can be considered complete, resulting in a number of reaction pots containing in-process molecules having the first oligonucleotide unit dT.

[0055] Figure 3 shows the second synthesis stage, where the reaction pot from the first synthesis stage is received and further processed. It is preferable that the same stations used in Stage 1 be used in Stage 2. In practice, the stations are intended to run Stages 1, 2, 3, etc., simultaneously. Certain steps, such as pre-synthesis washing and the first trityl removal step, may not be performed in the second synthesis stage. For clarity, note that stations 3, 5, 6, 7, and 8 from Stage 1 are reused in Stage 2, and station 9 for providing cytosine is added to the Stage 2 protocol.

[0056] Furthermore, any amidite can be processed in the second synthesis stage, and the synthesis of cytosine has been demonstrated. This can be achieved by adding a cytosine supply station 9. It is also intended that a complete station (supply container, pump, flow meter, valve block, analyzer, and residue recovery device) be provided for cytosine introduction. Additional stations can be added for each amidite contained in the molecule. In particular, since the synthesis apparatus can be configured to form any number of oligonucleotides, it is likely that stations will be provided for commonly used amidites or for all amidites.

[0057] Figures 4, 5, and 6 show further synthesis stages used to construct longer polymers, with the reaction pots from the preceding stages being sequentially introduced for the addition of amidite. Station 10 is provided to supply new amidite dG. However, pump (4) is used again for the second introduction of dT in stage 4. Station 9 is used for the second introduction of dC in stage 5. Figure 5 shows a new step in the synthesis process and also constitutes a repeat of step 1 of the protocol. Figure 6 shows a repeat of stage 2 of the sequence protocol.

[0058] This reuse of the amidite station can be repeated as needed to construct molecules of the desired structure and length. In this context, it is assumed that molecules of 2–300 Mer, or at least 100 Mer, or greater than 200 Mer, or greater than 300 Mer, may be produced (when considering polypeptides, base pairs are a suitable criterion). After synthesizing the desired molecules in multiple reaction pots, their contents can be combined in a larger storage container. The combined contents may be processed according to conventional oligonucleotide production / purification techniques.

[0059] This system can include more than 15 conveyor arrays that process more than 100 reaction pods to achieve molecules of the desired length. Generally, each conveyor array is expected to receive multiple (e.g., 7 or more) reaction pods.

[0060] It is assumed that the reactor of this disclosure can have a large number of reactions (e.g., more than 20) in a single row, and can provide multiple rows (e.g., more than 20). In this context, more than 400 reaction pots can be operated simultaneously, with most pots being at different stages in molecular construction. Generally, an exemplary reactor may have 5 to 25 reaction stations and include 5 to 10 rows.

[0061] Figure 7 shows the efficiency of this synthesis apparatus. For example, it is possible to provide a single supply container and supply device (station) for each step of the synthesis sequence. By providing separate pumps, flow meters, valves, and piping, a single reservoir can supply to the reaction pot in any of stages 1 to 5 (or more). Similarly, a single amidite reservoir can supply amidite to different steps in the synthesis sequence (e.g., thymine to stages 1 and 4).

[0062] Furthermore, reagents / reactants may be supplied at different concentrations at different steps of molecular synthesis. For example, it may be desirable to introduce more activators in stage 5 than in stage 1. Similarly, it may be desirable to add lower concentrations of coupling washes in later stages of the synthesis process. Likewise, the amount of amidite introduced can be varied depending on the number of reaction pots connected in a single reaction station.

[0063] Since pumps, flow meters, and valves do not need to be cleaned between steps of the synthesis process, further benefits can be obtained by using only one type of reactant / reagent at each reaction station. Similarly, there is no need to empty the equipment between reaction stages. In this context, a single station (e.g., thiolation) can be used to process multiple reaction pots at different stages of polymer synthesis.

[0064] Furthermore, the synthesis apparatus may include one or more stations containing one of the following units: cutting, deprotection, separation, filtration, membrane extraction, and / or chromatography.

[0065] Figure 8 shows that, with the exception of the coupling station, a single pump can be used for each station, and a pump can be supplied for each amidite used. Furthermore, some stations can include multi-block valves capable of supplying multiple feed streams simultaneously. Taking the coupling station as an example, the multi-block valve can simultaneously supply a feed stream of dT from station 4 to reaction pots connected in a row at stages 1 and 4, and a feed stream of dC from station 9 to reaction pots connected in a row at stages 2 and 5. Other stations can include multi-block valves to supply feed streams of different concentrations to different stages of the synthesis process. For example, it may be desirable to supply a higher concentration of NMI to the capping station at stage 5 than to stage 1. For clarity, note that “stage…” includes a schematic diagram of a conveyor plate mechanism (see 120 in Figure 9 below) containing “U”-shaped inlet / outlet pipes suitable for receiving reaction pots. This conveyor plate mechanism allows for the arrangement of reaction pots in appropriate arrays and spacings to most efficiently construct the desired biological polymer. Each stage array may be a separate plate from which the reaction pods are removed and attached to the next plate array, or the arrays may be mechanically integrated.

[0066] Figure 9 shows an exemplary reaction pot 100. The pot 100 may include a container 112 containing a reaction bed 113. The top surface 114 of the pot may include an inlet 116 for introducing a liquid supply stream into the top of the reaction pot and an outlet 118 for removing the liquid from the lower region of the pot after it has passed through the reaction bed 113. Gas may be introduced from the inlet 116 (or another passage) to assist in removal. The reaction pots 100 may be placed at each station and configured to fit substantially with a plate 120 including a sealable mating joint. The plate 120 can move vertically to engage / disengage with the reaction pots 110, and the reaction pots 110 move horizontally from station to station. However, it is assumed that the reaction pot transport mechanism can receive pots of different sizes and shapes. The reaction pots may be single-use (e.g., disposable containers and / or bags) or reusable, depending on the needs of the synthesis being performed.

[0067] Exemplary reaction pot sizes may range from approximately 1 to 100 mm in inner diameter, or from approximately 10 to 50 mm in inner diameter, and up to 150 mm in height. The effective dimensions of the support within the reaction pot are specified. For example, a support swollen with solvent may have a height of approximately 0 to 150 mm, or 5 to 30 mm, or 10 to 40 mm, and a diameter of over 0 mm to approximately 100 mm, or 10 to 50 mm. However, it should be noted that the shape of the container does not necessarily have to be cylindrical.

[0068] A relatively small volume (for example, 15 cm³) 3 By operating the system with multiple reaction pots (less than 1000 mm in diameter and 200 mm in height), mass transfer in the reactions occurring in each reaction pot is improved. Improved mass transfer has advantages such as a pressure drop of less than approximately 5 bar per reaction pot. Nevertheless, considering the system as a whole, using many reaction pots allows for larger reaction volumes than currently practical in batch processes (e.g., 2,000 mm in diameter, 200 mm in height = 3,140 cm²). 3A synthesis apparatus is provided that has ), whereas 200 reaction pots with a diameter of 40 mm and a height of 150 mm are provided, which have a capacity of 9,420 cm². 3 It provides the volume.

[0069] The reaction pot may include a temperature control device, a mixing device, a pressure regulator, and / or a pH regulator. It may be desirable to change the conditions of the reaction pot (e.g., temperature) between stations to optimize the environment for the process / reaction being carried out. The reaction pot may also include probes for monitoring at least one of the following: temperature, pressure, pH, conductivity, and time.

[0070] Each reaction pot can be individually marked (e.g., with a barcode) for identification. In this way, the characteristics of the molecules synthesized in each reaction pot can be stored in a database. This information may include, for example, the manufacturing stage, the expected or actual molecular structure, the manufacturing date, purity, etc.

[0071] In certain embodiments, reaction pods are moved simultaneously (but not necessarily at all stations simultaneously) between stations according to a set time (T). However, each step of the synthesis process may not be completed in the same time. Furthermore, at least one step may have the longest reaction time (R). Thus, reaction pods can move positions but remain at stations with a reaction time less than R for a time that is a multiple of T (the multiple may be an integer). In this context, at some stations, reaction pods may be retained at the station while that station is inactive.

[0072] In startup mode, containers may be moved after a reaction time of a fraction of T until at least one container is associated with each station. After the startup, at least one reaction vessel can be placed in each station, and the normal movement rate T begins. Depending on the molecules formed, each reaction pot is expected to move every few seconds to 10 minutes, or every 1 / 2 minute to 5 minutes.

[0073] Figure 10 illustrates a concept of the synthesis apparatus of the present invention operating serially according to a set time interval. Furthermore, each step is configured to have a pot position equal to the expected reaction time. For example, the detritylation step has a reaction time of 3 minutes and three corresponding pot positions, and can simultaneously receive feed liquid (e.g., DCA / toluene) from one feed. In this configuration, each pot can follow the pots that are moving forward in the entire assembly.

[0074] Figure 11 illustrates the concept of the synthesis apparatus of the present invention operating in parallel according to a set time interval. Furthermore, the number of pots in a station corresponds to the associated reaction time. For example, two pots remain in the first detritylation station, and DCA / toluene is supplied sequentially from the first pot to the second of the two pots. In this configuration, the pots do not follow the preceding pot but move to positions for longer reaction steps. In both the protocols of Figure 10 and Figure 11, the intention of this configuration is to keep each pot in the station for a sufficient amount of time to complete the reaction. In that context, it is assumed that serial and / or parallel strategies can be used together or interchangeably in the station.

[0075] At the end of the construction of the desired polymer, this procedure intends to remove the reaction pot containing the desired polymer from the synthesis apparatus array. Similarly, this procedure intends that a station that has completed supplying the final reaction pot can cease introducing its designated reagents / reactants. In this context, it is assumed that each station may include the supply of cleaning fluid (potentially from a centralized reservoir of cleaning fluid). In this way, the pot ending the cycle can receive the cleaning fluid used to terminate each station in the array, following the reaction pot that last constructed the polymer. An example cleaning fluid is ACN.

[0076] Furthermore, it is conceivable that excess reagents / reactants from individual stations could be supplied to different stations along the row, or even to stations in different rows, for recycling. This is possible at any point in polymer construction, and if adopted at the end of the cycle, terminated reaction stations can further supply the array of active reaction stations. For example, instead of recycling ACN from station 1 to the supply container of station 1, it could be recycled to station 5 (or another suitable station) to conserve raw materials, improving operational efficiency, especially at the end of the process.

[0077] While specific reagents and reactants are illustrated, the disclosure is not limited to these examples or sequences. Rather, those skilled in the art will recognize that countless variations in synthetic sequences are possible.

[0078] The synthesis apparatus can also be configured to distribute the reaction solution for synthesizing the polypeptide. The peptide synthesis process on a solid support generally involves constructing the peptide from a carboxyl terminus. The peptide is bound to the solid support via an amino acid at its carboxyl terminus and further contains a protecting group on the α-amino group at its amino terminus. The protecting group is then cleaved from the peptide to form a deprotected peptide. Next, a monomeric amino acid containing a protected α-amino group is brought into contact with the deprotected peptide under conditions that form a peptide bond between the α-amino group of the deprotected peptide and the α-carboxyl group of the monomeric amino acid. The monomeric amino acid may be provided in an activated form, or an activating reagent may be added to the amino acid and the elongated peptide. Washing can be performed between steps to remove the reagent. The cycle of deprotecting the next amino acid and coupling the additional amino acid can be repeated until a peptide of the desired length is synthesized. Any reactive side chains of an amino acid are generally protected by chemical groups that can withstand the coupling and α-amino group deprotection processes. However, these protecting groups on the side chains may be removed at the end of the synthesis. The station arrays and the schedules in which the arrays cooperate with each other can be correlated according to the teachings herein and known reaction schemes for peptide synthesis, for example, those described in Goodman et al., Synthesis of Peptides and Petidomimetics, Vol. E22a, Georg Thieme Verlag, Stuttgart, 2002.

[0079] The following examples are presented for illustrative purposes only and are not limiting.

[0080] Oligonucleotides are produced using the apparatus described herein, following physical steps including supplying fluid to multiple reaction pots and draining waste liquid from the reaction pots. A computer is programmed to supply the appropriate reactants to designated reaction pots in a specified order.

[0081] Oligonucleotide synthesis involves deprotection, condensation, oxidation, and capping. Deprotection is the removal of the acid-unstable DMTr group from the 5'-OH group of the sugar moiety. Condensation is the coupling of excess activated monomers to the growing chain. Oxidation is the oxidation of the 3'-5' internucleotide phosphite triester linkage to the more stable phosphotriester linkage. The polymer is then treated to remove the protecting group, thereby generating a phosphodiester linkage. The capping step is to cap the 5'-hydroxyl group that did not condense as an acetate ester. A typical protocol is: 1. Wash the support; 2. Dispense liquid containing a deblocking agent to remove the protecting group; drain; 3. Dispense liquid containing the protected nucleotide and coupling activator; drain; 4. Dispense liquid containing the capping agent; drain the liquid; wash the support; drain the liquid containing the oxidizing agent. The steps are repeated until the nucleotide sequence is complete.

[0082] Polypeptide synthesis may involve: 1. the addition of amino acids to the nascent polypeptide chain; 2. deprotection by removing a protecting group (Fmoc or Boc) to make the α-amino group at the end of the elongated peptide chain available; 3. coupling by activating the amino acid residue to an active ester and then forming an amide bond with the deprotected α-amino group at the end of the elongated peptide chain; and 4. capping the unreacted α-amino group with the same reagents used in DNA / RNA synthesis. In synthesis using Fmoc, the base-unstable protecting group (Fmoc) is removed in each cycle. At the end of the synthesis, the side-chain protecting group is removed with a weak acid, and the bond fixing the peptide to the support is also cleaved. In synthesis using Boc, the Boc protecting group is acid-unstable and can be removed with a mild acid. A strong acid is used in the final deprotection and cleavage step.

[0083] A protocol for peptide synthesis using Fmoc chemistry may include the following steps: 1. Deprotection (at least once) - piperidine, twice - 7 minutes; 2. Drain; 3. Wash (at least once) - N-methylpyrrolidone (NMP) or dimethylformamide (DMF), six times; 4. Coupling - 18 seconds of activation + 35 minutes of coupling; 5. Drain; 6. Capping [optional] - 1 minute; 7. Drain; 8. Wash (at least once) - NMP or DMF, three times. Steps 1-8 are repeated until the amino acid sequence is complete. A protocol for peptide synthesis using Boc chemistry may include the following steps: 1. Wash (at least once) - chloromethane (DCM), once; 2. Deprotection (at least once) - trifluoroacetic acid (TFA), twice - 6 minutes; 3. Drain; 4. Wash (at least once) - chloromethane (DCM), once; 5. Wash (at least once) - NMP or DMF, 6 times; 6. Coupling - 18 seconds of activation + 35 minutes of coupling; 7. Drain; 8. Capping [optional] - 1 minute; 9. Drain; 10. Wash (at least once) - NMP or DMF, 3 times. Steps 1-10 are repeated until the amino acid sequence is complete.

[0084] Exemplary embodiments have been described with reference to preferred embodiments. Clearly, the above detailed description may prompt others to conceive of modifications and changes. Exemplary embodiments are intended to be construed as including all such modifications and changes only within the scope of the appended claims or their equivalents.

[0085] To assist the Patent Office and readers of this application and the resulting patents in interpreting the claims attached to this application, the applicant has no intention of invoking Section 112(f) of 35 U.S.C. in any of the attached claims or claim elements unless the terms “means for” or “steps for” are expressly used in any particular claim.

Claims

1. An apparatus for the multi-step synthesis of organic molecules, comprising: (a) a plurality of reaction vessels; (b) a plurality of fluid reservoirs; (c) valve elements associated with the fluid reservoirs; (d) a fluid supply device for providing a feed stream from the fluid reservoirs to the reaction vessels; (e) a plurality of devices capable of monitoring the chemical composition of effluents from the plurality of reaction vessels; and (f) a conveyor having the programmed pattern suitable for sequentially transporting the reaction vessels from one fluid engagement with the fluid reservoir to the next fluid reservoir according to the programmed pattern, An apparatus in which at least two of the reaction vessels simultaneously receive fluid from at least one of the fluid reservoirs, and the fluid from the at least one fluid reservoir is introduced into a first reaction vessel among the at least two of the reaction vessels, and introduced from the first reaction vessel into a second reaction vessel among the at least two of the reaction vessels.

2. The apparatus according to claim 1, wherein each of the fluid reservoirs comprises a reaction and / or processing station, and at least one station is simultaneously connected to at least two of the reaction vessels arranged in a row.

3. The apparatus according to claim 2, wherein the fluid reservoir is connected to the reaction vessel as a counter-current flow mechanism.

4. The apparatus according to claim 1, comprising at least 100 of the reaction vessels.

5. The apparatus according to claim 1, comprising at least X fluid reservoirs and at least Y reaction vessels, wherein Y > X.

Images